50 filings
8-K
ZURA
Zura Bio Ltd - Ordinary Shares
14 Jun 24
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
6:04am
8-K
ZURA
Zura Bio Ltd - Ordinary Shares
6 Jun 24
Regulation FD Disclosure
6:03am
8-K
ZURA
Zura Bio Ltd - Ordinary Shares
3 Jun 24
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
6:02am
8-K
ZURA
Zura Bio Ltd - Ordinary Shares
29 May 24
Zura Bio Announces Participation in June Investor Conferences
6:05am
8-K
ZURA
Zura Bio Ltd - Ordinary Shares
9 May 24
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
6:07am
8-K
znq7dmg
22 Apr 24
Entry into a Material Definitive Agreement
8:21pm
8-K
393jtxj4yaf8bee70b
8 Apr 24
Zura Bio Announces Robert Lisicki as CEO and Director
6:04am
8-K
az4mpym1a47op7
28 Mar 24
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
6:02am
8-K
fjg5lncb vmoarsy
11 Mar 24
Regulation FD Disclosure
6:04am
8-K
s5g3ifzgyugf27
4 Mar 24
Zura Bio Announces Participation at March Conferences
6:03am
8-K
vmjqetj0oyy fzx8jv
23 Feb 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
m0kyoqtd
2 Feb 24
Zura Bio Announces Participation at February Investor Conferences
6:02am
8-K
4dmxacsqt 13
11 Jan 24
Regulation FD Disclosure
5:25pm
8-K
7hwcx2fiplastvggjbwv
8 Jan 24
Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
6:03am
8-K
1kt75kjovz1a
3 Jan 24
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
6:04am
8-K
a0vh531jcihj
6 Dec 23
Departure of Directors or Certain Officers
4:31pm
8-K
aca6gth37au5sibav
4 Dec 23
Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok
6:06am
8-K
7zy bha6quk5
14 Nov 23
Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
6:02am
8-K
fqvdn0 a3
25 Oct 23
Regulation FD Disclosure
4:30pm
8-K
v9dsz9h4mq mmxd
2 Oct 23
Departure of Directors or Certain Officers
9:30pm